713 related articles for article (PubMed ID: 16297351)
1. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats.
Nishiyama T
Acta Anaesthesiol Scand; 2006 Feb; 50(2):228-33. PubMed ID: 16430547
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
[TBL] [Abstract][Full Text] [Related]
5. PC-407, a celecoxib derivative, inhibited the growth of colorectal tumor in vitro and in vivo.
Li Y; Niu Y; Wu H; Zhang B; Sun Y; Huang H; Li Q; Fan L; Liu L; Mei Q
Cancer Sci; 2009 Dec; 100(12):2451-8. PubMed ID: 19814734
[TBL] [Abstract][Full Text] [Related]
6. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice.
Ayoub SS; Colville-Nash PR; Willoughby DA; Botting RM
Eur J Pharmacol; 2006 May; 538(1-3):57-65. PubMed ID: 16674937
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages.
Shen F; Bai AP; Guo ZR; Cheng GF
Acta Pharmacol Sin; 2002 Aug; 23(8):762-8. PubMed ID: 12147201
[TBL] [Abstract][Full Text] [Related]
8. Mathematical analysis of involvement ratio between central and peripheral COX-2 in rat pain models with two types of COX-2 inhibitors with different distribution, celecoxib and CIAA.
Okumura T; Sakakibara A; Murata Y; Kita Y
Eur J Pharmacol; 2008 Jan; 578(1):97-9. PubMed ID: 17716650
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
10. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
Lee IO; Seo Y
Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448
[TBL] [Abstract][Full Text] [Related]
11. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
13. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents.
Abdel-Aziz HA; Al-Rashood KA; ElTahir KE; Suddek GM
Eur J Med Chem; 2014 Jun; 80():416-22. PubMed ID: 24794773
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effects of benzoisoselenothiazolidone sulfonamide derivatives on cyclooxygenase].
Guo Y; Xiao YX; Guo ZR; Cheng GF
Yao Xue Xue Bao; 2001 Oct; 36(10):735-8. PubMed ID: 12579970
[TBL] [Abstract][Full Text] [Related]
18. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor.
Okumura T; Murata Y; Hizue M; Matsuura T; Naganeo R; Kanai Y; Murase A; Sakakibara A; Fujita I; Nakao K
Eur J Pharmacol; 2006 Jun; 539(1-2):125-30. PubMed ID: 16690052
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
